← Back to your selection

Bertelsmann Healthcare Investments

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$65M
2 disclosed · full round size, not this investor’s share

By stage

Series A1
Series B1

By primary sector

Biotech1
Healthtech1

By country

Austria1
Israel1

Rounds

2 in this selection
QuantHealth

AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment

$45MSeries B
Role not disclosed
Flinn

Develops AI-based software to automate regulatory and quality processes in medtech and pharma

$20MSeries A
Role not disclosed